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INTRODUCTION 
Renal transplantation is  the treatment of  choic e for  better 
quality of  life in end s tage renal disease patients.1  The long term 
succ ess of  renal transplantation depends largely on the prevention 
of  allograft rejection.  In renal transplant patients,  a s tate of 
generalized non-spec if ic  immunosuppress ion has  been induced to 
prevent the rejection of  graft by us ing various  drugs  (such as 
corticos teroids,  cyc losporine,  tacrolimus,  azathioprine and 
mycophenolate mofetil).     
The immunosuppress ion induced by drugs  to prevent the graft 
rejection renders  the renal transplant rec ipients  more susceptible to 
bacterial, viral and fungal infections  and predisposes  to the various 
dermatos is, premalignant and malignant skin c onditions w hich may 
cause s ignif icant morbidity and mortality.  The consequenc e of 
immunosuppress ion differs  markedly w ith geographic al loc ation, 
rac ial group and skin type.1  
The present study is undertaken to f ind the prevalence and to 
identify spectrum of skin diseases  in renal transplant rec ipients  in 
our c entre.  
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REVIEW OF LITERATURE 
INFECTION IN RENAL TRANSPLANT RECIPIENTS 
Infection is  the most common immediate cause of  death in 
renal transplant rec ipients  because of  the c onc urrent 
immunocompromisation assoc iated w ith immunosuppress ive drug 
therapy.  Infection in an immunocompromised host differ  from that 
of  an immunocompetent individual in many ways.  This  is  depicted 
in the WOLFSON’S c lass if ication3  of  dermatologic al infection in 
immuno compromised patients  (based on the presumed underlying 
pathophys iologic mechanisms).   
FOUR CATEGORIES ARE DESCRIBED 
1) Infection that originates  in the skin w ith the c ommon 
organism that has  the potential for  more spread than in the 
normal host.  
2) Extens ive skin involvement w ith an organism that usually 
causes  local infection in a normal hos t can lead to severe 
involvement in the immunocompromised hos t.  
3) Infection w ith an opportunistic  organism that causes  primary 
infection in the skin can produce either  local or systemic 
dissemination.  
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4) Involvement of  the skin by dissemination from a systemic 
disease elsewhere in the body.  
In addition to the above,  some of the unusual pathogens 
produc e c linic al conditions  that resemble usual infection but may 
not respond to routine antimicrobial therapy.  Bec ause of  the 
depressed host inflammatory responses  diff iculty is  alw ays 
encountered not only in the diagnos is but also in the treatment of 
various infec tions in transplant rec ipients.2  
DEFEC TS IN HOST DEFENC E AND TYPES OF INFECTION 
IN RENAL TRANSPLANT RECIPIENTS 
In renal transplant patients  humoral immunity is  relatively 
spared.  They are more prone to develop granulocytopenia (defined 
as less  than 500 polymorphonuc lear  leukocytes  per  cubic 
millimeter)  and particularly at r isk for  disseminated infection w ith 
both aerobic  gram negative organisms  and fungi.2  The extens ive use 
of  broad spectrum antibiotics,  intravenous  cannula and central 
catheters  in these patients  further  results  in dissemination of 
infection.8  
 In addition,  the effect of  chronic  corticosteroid therapy on 
the skin by depress ing of  f ibroblast proliferation,  inhibiting of  the 
 4
depos ition of  c ollagen and synthes is  of  mucopolysaccharides  leads 
to atrophic  skin w ith poor wound healing.  So even minor skin 
trauma c ombined w ith an occ lus ive dress ing can lead to severe 
disseminated infec tion from an organism that gains  entry by this 
route.2  
The renal transplant rec ipients  are more prone to develop 
cellular  immune dysfunc tion bec ause of  the immunosuppress ive 
agents used.  The organisms  caus ing infec tion in these patients  are 
fungi such as  dermatophytes,  c andida spp,  cryptococcus  spp, 
histoplasma spp,  the herpes group of viruses (Herpes  s implex, 
Varicella-zos ter,  Cytomegalovirus,  Eps tein-barr  virus  )  and 
adenovirus, noc ardia, mycobacteria.5  
Different types  of  infections  tend to occur at f ixed point of 
time during the post transplant period which c an be divided into 
three dis tinct phases.7  
1) During the f irst month of pos t transplantation 
2) During 1-6 months, after transplantation 
3) Six months after the transplantation.  
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INFECTIONS DURING THE FIRST MONTH OF POST 
TRANSPLANT PERIOD 
It comprises of three types 
1) Infection present in the allograft rec ipient prior to the 
transplantation gets exac erbated by the immunosuppress ive 
therapy (eg: bacterial infection like tuberculos is  and 
geographic ally res tr icted sys temic  myc os is  (bls tomycos is, 
cocc idioidomycos is and histoplamosis ).  
2) The infection that is transmitted via the contaminated 
allograft.  
3) The bacterial infection of  the surgic al wound,  intravenous  and 
bladder c atheters.5  
INFECTIONS DURING 1 TO 6 MONTHS OF POST 
TRANSPLANTATION 
During this  period,  problems due to infections  that are unique 
to transplantation begin to occur.  
The most important group of infections are  
1) Viral infections 
a. Herpes  group of  viruses-  latent viruses  reactivation- 
symptomatic disease 
b. Hepatitis viruses  
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2) Opportunistic  infection w ith agents  like Pneumocys tis  c arinii, 
Lis ter ia monoc ytogens.  These infections  are bec ause of  the 
combined effects  of  immunosuppress ive therapy and the 
immunomodulating effects  of  the viruses  particularly 
cytomegalovirus.62  
INFECTION THAT OCCUR AFTER 6 MONTHS OF 
TRANSPLANTATION 
This can be discussed under three categories  
1) During this  period interaction between the chronic 
immunosuppress ive s tate and the active replic ation of  viral 
agents  results  in transplant patients  becoming  more prone to 
develop the follow ing infection.  
a. Progress ive chorioretinitis due to c ytomegalovirus  
b. Hepatoc ellular c arc inomas due to hepatitis B virus  
c. Epstein-barr virus assoc iated lymphoproliferative disease 
d. Human papilloma virus infec tion5  
2) Patients  w ith good renal function,  receiving only minimal 
immunosuppress ive therapy are at particular  r isk for 
development of c ommunity ac quired infection.  
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3) Patients  w ith relatively poor renal function and receiving 
intense immunosuppress ive therapy are prone to develop 
chronic  viral infection and life threatening opportunistic 
infections  w ith pathogens such as  Pneumocystis c arinii, 
Cryptococcus  neoformans,  Listeria monocytogens  and 
Noc ardia asteroids.63  
FUNGAL INFECTIONS IN RENAL TRANSPLANT 
RECIPIENTS 
In mid 1980s,  Ric hard w enzel of  Univers ity of  Virginia 
provided some of the f irs t evidenc e that fungal infections  begin to 
r ise in the population of  patients  w ith impaired immune system due 
to acquired immune defic iency syndrome,  c ancer,  chemotherapy or 
drugs  des igned to prevent rejection of  transplanted organs.4  Rec ent 
studies  highlighted the alarming increase of  the opportunistic 
fungal infections in an immunocompromised hos t.2  
The onset of  fungal infection is usually betw een 1-6 months 
after  immunosuppress ion.  The further  interesting observation w as 
that the rarer  organism cons idered as  the contaminants  or 
saprophytes  are becoming increas ingly pathogenic  and even fatal in 
immunocompromised patients.5  
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The skin may be involved as a result of  primary inoc ulation 
or  by seeding of  the skin from systemic  infection.  In disseminated 
infections,  the c utaneous  les ions  may be the initial s ign of 
underlying infection and may provide a convenient sourc e of  tissue 
for  diagnos is.  The most c ommon opportunistic  fungi that infect 
immunocompromised hosts  are Candida spp,  Cryptococcus  spp and 
Zygomyc etes.6  
The r isk of  the infection in these patients  is  determined by the 
interaction between the epidemiologic al exposure that the patient 
experienc es and the net state of  immunosuppress ion.  The causative 
mic roorganisms  vary depending upon the types  of  immune 
dysfunction.  The infection can be broadly divided into those that 
take the advantage of  a neutrophil defect (candidias is  and 
mucormycos is) and those that take the advantage of T cell and 
mononuc lear phagoc yte defect (cryptococcos is, histoplasmosis).6  
Opportunistic  fungi that rarely infect healthy person can have 
very high inc idenc e in these patients.  Candida albicans  is  the 
pathogen most often isolated, but several other c andida spp may 
also cause infection.10  
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The poorer  prognos is  for disseminated fungal infection in 
immunocompromised patients c an be attr ibuted to the underlying 
immunocompromised s tatus  of  the patient,  delay in diagnos is  due to 
atypic al presentation,  delay in initiating treatment and failure of  the 
antifungal regimen.6  
The various  fungal infections  that are encountered in renal 
transplant rec ipients  
1) Superfic ial fungal infec tions  
a. Dermatophytos is  
b. Pityrias is vers icolor  
c. Candidias is  
2) Subc utaneous fungal infections  
a. Phaeohypomycos is  
3) Oppurtunistic fungal infections 
a. Cryptococcos is  
b. Zygomyc os is  
c. His toplasmosis  
d. Aspergillos is  
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DERMATOPHY TOSIS 
Dermatophyte infections  common in patients  w ith long 
duration (more than one year)  of  post- transplant 
immunosuppress ion.39  The rate of dermatophyte carr iage on 
c linic ally normal skin w as  estimated as  12% in renal transplant 
rec ipients c ompared w ith 6.8% in a control population.36  
Cell mediated immunity,  espec ially by epidermal Langerhans 
cells,  is  the main defense mechanism agains t dermatophytes,  and its 
inhibition by immunosuppress ive drugs  predisposes  solid-organ 
transplant rec ipients to dermatophytos is .9  
In a normal host,  dermatophytos is  typic ally presents  as 
superfic ial sc aly les ion w ith active border show ing inflammation 
and c entral c learanc e. How ever in immune compromised patients 
w idespread non-inflammatory cutaneous  les ions  w ith ill-defined 
margin and profuse scaling are noted.10  
The c ommon s ites  for  dermatophyte infection in renal 
transplant rec ipients  are groin,  trunk, feet and hands.  In these 
patients,  tinea cruris  was  the c ommenes t type noted,  follow ed by 
tinea corporis and tinea glutealis.11  
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Deep form of dermatophytos is  has  been frequently described 
w ith systemic immunosuppress ion. Cases of  follic ular  papules  or 
nodules  (Majjochi’s  granuloma) and multiple subcutaneous 
neutrophilic  abscess  has  been reported in renal transplant patients.94 
On rare occas ions,  invas ive dermal or  subcutaneous  infection 
develop after trauma or follic ular rupture.12  
In renal transplant rec ipients, the isolation of  organisms from 
cutaneous  dermatophyte infection revealed,  T. rubrum as  the 
common isolate (80.8%) follow ed by T.  mentagrophytes  (11.5%), 
E. f loccosum and T. s imii (each 3.8%).11  
Fingernail infections  and involvement of  multiple nails  are 
seen more commonly in immunocompromised patients  than in other 
patients. Among the various  c linic al presentation of  tinea unguium, 
proximal subungual white onychomyc os is  (PSWO) is  commonly 
seen in immunoc ompromised (HIV) patients.15 ,44  
Although PSWO w as cons idered to be a c lue to HIV 
infection,  the affected persons  did not show  the presence of  HIV 
antibodies  through ELISA technique,  and therefore it could be 
inferred that PSWO might be a manifes tation of 
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immunosuppress ion not only due to HIV infection but also due to 
iatrogenic  induction.11  Tric hophyton rubrum was  the mos t c ommon 
pathogen isolated. Occass ionally T.  megninii, T. schonelinii and E. 
f loccosum w ere also isolated. Among the 100 kidney transplant 
patients, 3 patients showed PSWO les ions.11  
The immunosuppress ive therapy enhances  the r isk of failure 
of  antifungal therapy and prolonged treatment as  w ell as  c lose 
follow-up is  essential to ensure complete cure of dermatophytos is 
in renal transplant rec ipients.10  
PITYRIASIS VERSICOLOR 
Pityrias is  vers icolor  is  a c ommon fungal infection in renal 
transplant patients  and more c ommon than the general population.16  
The prevalenc e of   infection w ith Malassezia spec ies  is  increased 
among renal transplant rec ipients,  probably ow ing to the 
immunosuppressed state of  this patient population.98 Pityrias is 
vers ic olor  manifes ts w hen there is a shift in the yeast form to the 
mycelial form that is  commonly seen in renal transplant rec ipients 
due to cortic osteroid therapy.79  
The c linical features  are s imilar  to those observed in 
immunocompetent patients,  however the les ions  are more likely to 
 13 
be non pruritic and less  inflammatory,  and they generally involve 
large areas of body. Flexural distr ibution is also seen.80   
Pityriosporum folliculitis  presents  as  itchy monomorphic 
papulo pustules  over the trunk and upper extremities,  commonly 
seen in young individuals.17  Onyc homycos is and fungaemia w ere 
rarely reported in immunocompromised patients.46  
CANDIDIASIS 
Candidial infections  are common opportunistic  fungal 
infections  in solid organ transplant patients  and more prone to 
develop pers istent and severe oral candidias is.13  In general, defect 
in neutrophil and monoc yte phagoc ytic  func tion,  whic h are seen 
soon after  the renal transplantation, predisposes  patients to develop 
infections  w ith Candida spec ies. The glucocortic oid therapy in 
renal transplant patients  induces  alteration in monocyte defense 
against c andida by decreas ing TNF-α levels.18  
Oral colonization w ith c andida spec ies  is  a common problem 
in renal transplant rec ipients. Commonly isolated spec ies  w ere 
Candida albic ans,  Candida tropicalis  and C.glabarata.  Renal 
transplant rec ipients,  on oral Fluconazole prophylaxis  are more 
prone to get infection w ith Candida krusei and Candida glabarata 
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bec ause these pathogens  are less  sens itive or  res istant to 
Fluconazole.81     
 The most common form of yeas t infection in 
immunocompromised patients  is  oral candidias is.  The les ions  of 
oral candidias is  presents  as  geryish white pseudomembrane w ith 
underlying erythema,  and eros ion and f issures  w ith mac eration in 
the angle of mouth.18  
Cutaneous  involvement occured in 13% c ases  of  disseminated 
candidias is.  The skin les ions  in disseminated c andidias is  manifes ts 
as  discrete,  f irm,  raised pink or  red coloured nodules,  multiple 
asymptomatic  erythematous  macules,  pustules  and purpura w ith 
assoc iated fever and musc le tenderness.  Nodules  w ith pale c entre 
and painless  nodulopustular  les ion w ith c entral necros is  and 
seropurulent discharge may also be reported in disseminated 
candidias is.38  
 PHAEOHYPOMYCOSIS 
Phaeohypomycos is  is  a heterogenous  group of  opportunistic 
fungal infections c aused by dematiac eous molds(dark pigmented 
fungi)  whic h are ubiquitous  in nature,  but rarely causes  human 
disease.19  In recent years,  these fungi are  recognized as  important 
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human pathogens  because of  increased numbers  of 
immunocompromised patients  inc luding renal transplant 
rec ipients.20  
In humans,  the commonly isolated pathogens  are Alternaria,22 
Bipolaris,  Curvularia,  Exophiala,  Exserohilum and more than 100 
spec ies  have been isolated from phaeohypomycotic  les ions.21  These 
organisms  are usually found in soil,  polluted w ater  and dec aying 
vegetation.23  
The extremities  are commonly involved bec ause the mode of 
transmiss ion of  these saprophytic  fungi is  mainly by  traumatic 
implantation.  Phaeohypomycotic  cutaneous  les ions  have variable 
c linic al presentation like subcutaneous  cysts,  nodules  and 
absc esses.19  
 CRYPTOCOCCOSIS 
The disease is  caused by an yeas t,  Cryptoc occus neoformans, 
w idespread in soil and the route of  entry is  via respiratory tract by 
inhalation of  spores. Skin may also be an portal of  entry for 
cryptococcus  and acts as  an potential source for subsequent 
progress ion to disseminated cryptoc occos is in solid organ 
transplant patients.24  Depressd c ell mediated immunity results  in 
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disseminated cryptococcos is  in renal transplant rec ipients. Rarely 
primary cutaneous cryptococcos is manifes ts in transplant patients.24  
 Cutaneous manifes tation of disseminated cryptococcos is  
occurs in about 10%-15% of c ases.  Various c utaneous  les ions  in 
disseminated cryptoc occos is  are papules,  ac neiform pustules, 
nodules,  subcutaneous  absc esses,  molluscum contagiosum like 
les ions and as cellulitis.25 ,26   
ZYGOMYCOSIS 
Zygomyc os is  is  c aused by muc orales,  commonly seen in 
diabetic  ketoac idis is,  lymphoma,  leukaemia and renal transplant 
patients on immunosuppress ive therapy.  A s tudy review ed 361 
cases  of  zygomycos is  and the mos t c ommon pathogen isolated w as 
Rhizopus followed by Mucor, Abs idia in decreas ing order.28   
HISTOPLASMOSIS 
His toplasmosis  is  caused by dimorphic  saprophytic  fungus, 
His toplasma capsulatum.   Inhalation of  airborne spore is  the usual 
route of  infection.   Dissemination occurs  in renal transplant 
rec ipients  due to depressed cell mediated immunity by 
immunosuppress ive drugs.59 Primary cutaneous  histoplasmosis  is 
very rare infection usually occurs by local trauma or inoc ulation  
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and cutaneous  les ions  may present as  papule,  pus tule or  plaque, 
ulcers and wart like les ions.58  
 In renal transplant patients, disseminated histoplasmosis 
manifests  as pers istent punched out c ircumscribed granulomatous 
ulcer,  painful erythematous  rash,  plaques  and nodules  resembling 
erythema nodosum, molluscum c ontagiosum like les ions  over face 
and erythema multiforme.58  
ASPERGILLOSIS 
In immunocompromised patients  aspergillos is  is  one of  the  
common opportunis tic  fungal infection.  Aspergillus  infection 
occurs c ommonly in patients  w ith haematologic  or  lymphoreticular 
malignanc ies or  on immunosuppress ive therapy. Aspergillus 
fumigatus causes most of the disseminated infection.6  
Primary cutaneous  aspergillos is  usually manifests  as  s ingle or 
multiple pruritic  erythematous  indurated plaque often resembling 
cellulitis  and may undergo necros is  and ulc eration.  Lymphatic 
dissemination of infection results  in multiple les ions.  In 
disseminated aspergillos is  the cutaneous  manifestations w ere 
haemorrhagic bullae, purpuric nodules and c ellulitis.2  
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PENICILLIOSIS 
Penic illium marneffei is  a dimorphic  fungus,  a rare pathogen 
whic h affects  many patients w ith HIV and other 
immunosuppress ive states.  Cutaneous  les ions  are small umblic ated 
papules  resembling molluscum contagiousum w hich may later 
undergoes ulceration.6    
VIRAL INFECTIONS 
Viral infec tions  have great impact on quality of  life in renal 
transplant patients because of  latency,  recurrence and chronic ity. 
The combination of  c hronic  immunosuppress ion and chronic ity 
w ith the herpes  group of  viruses, the hepatitis viruses,  the papova 
viruses  and HIV has  resulted in an array of  c linic al syndrome in the 
transplant patients which are rarely encountered in the normal host.  
HERPES VIRUS 
The four major human herpes  viruses,  herpes  s implex virus 
(HSV),  Varicella-Zos ter  virus  (VZV),  Epstein-Barr  virus  (EBV) 
and Cytomegalovirus  (CMV) shares  three characteristics  that 
explains their great impact on the renal transplant patients.  
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LATENCY 
Primary infection results  in life long c arr iage of  non-
replic ating,  transcriptionally inactive virus,  that c an be reactivated 
by immunosuppresss ion and allograft rejection.  Anyone who has 
antibody agains t a herpes  virus  in his  or her serum (seropos itive), 
harbours the latent virus.36  
CELL ASSOCIATION 
The ability of  the virus  to spread by c ell to c ell direct c ontact 
reduces  the chance of  antibody mediated neutralization.  Cell 
mediated immunity is  of  prime importanc e in the c ontrol of  such 
infection.  This c ell mediated immunity is depressed by 
immunosuppress ive agents administered in transplant patients.60  
ONCOGENECITY 
All the herpes viruses  should be cons idered as potentially 
oncogenic  espec ially in the presence of  c hronic  immunosuppress ion 
of which most important is  EBV assoc iated lymphoproliferative 
disorders.64    
HERPES SIMPLEX  
Herpes s implex virus  infec tion c ommonly occurs during 2 -  6 
months  of  post transplant period.  Localised mucocutaneous  herpes 
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s implex virus  infection of  oral and anogenital region usually occur 
as recurrence in renal transplant rec ipients  under 
immunosuppress ion.  The les ions  that occurs in the ano-genital 
region may have atypic al morphology like pers istent ulc eration, 
deep necrotic  ulc er,  hyperkeratotic  and verrucous  les ions.60  In renal 
transplant patients, reactivation of  HSV is  common,  whic h results 
in asymptamatic  viral shedding or  may lead on to progress ive 
mucocutaneous infection w ith cons titutional symptoms.47  
VARICELLA (CHICKENPOX) 
Varicella is  c aused by Varicella-Zoster  virus  (VZV) and 
uaually a febrile illness  manifests  as generalized ves ic ular  les ions 
w ith central depress ion soon becomes  crusted and heals  w ith 
superfic ial scars  and pos t- inflammatory hyperpigmentation.  Cell 
mediated immunity to VZV pers ists  for  many years and gives 
protection agains t severe infec tions.  The les ions  may pers ist longer 
and disseminated varicella w ith visceral involvement occurs  in 
immunocompromised persons  due to inadequate development of 
cell mediated immunity.27      
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HERPES ZOSTER 
Herpes  zoster  infection occurs 2-24 months  after  renal 
transplantation.  This  infec tion is  usually reactivation of  VZV 
produc ing localized zoster, rarely disseminated one in the form of 
multidermatomal dis tr ibution w ith more of  haemorrhagic les ions 
w ith necros is and midline cross ing.29  
CYTOMEGALOVIRUS 
Cytomegalovirus  is  the most important infectious agent in 
organ transplant patients.  CMV affec ts at leas t two thirds  of 
transplant patients  and occurs  commonly during 1 to 4 months  of 
post transplant period.  The immunomodulating ability of  the virus 
predisposes  the renal transplant patients  to acquire opportunistic 
infection and allograft injury.62  
Cutaneous  eruption develops  in 10- 20% of patients  which 
may present as   indurated hyperpigmented nodular  les ions,  plaques 
and ves ic ulo-bullous  les ions.  Ulceration may occur on the perianal 
region, rectal mucosa, gluteal region and thigh.61 ,63  
EPSTEIN-BARR VIRUS 
EBV infection usually occurs  1 to 4 months after  organ 
transplantation.  In renal transplant rec ipients,  cyc losporine therapy 
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increases  the chance of  acquir ing EBV induc ed lymphoproliferative 
disorder.64  Oral hairy leukoplakia c aused by EBV ,  mostly seen in 
AIDS patients,  has  also been reported in HIV negative transplant 
patients.65  
MOLLUSCUM CONTAGIOSUM 
Mollusc ipox virus  a DNA virus  belongs  to Poxvir ida family, 
commonly infects  children, sexually active adults  and 
immunocompromised individuals either  directly by c lose skin 
contact or  indirectly through fomites.95  Molluscum 
contagiosum(MC) les ions  commonly involve face,  genital areas  as 
umbilic ated skin coloured or shiny papules.96  
In immunocompromised persons, multiple and giant les ions 
have been reported.  Histopathologic al examination of  MC les ions 
are mandatory in renal transplant rec ipients  because cryptococcos is, 
histoplasmosis,  c occ idioidomyc os is  and penic illios is  may present 
as  molluscum contagiosum like les ions  in immunocompromised 
patients.96  
HUMAN PAPILLOMA VIRUS 
Cutaneous w arts  usually develop one year  after  the 
transplantation. Cell mediated immunity (CMI) is  the princ iple 
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mechanism in rejection of  warts  and defects  in CMI results  in more 
number of  les ions  and pers istent les ions.49  Epidermodysplas ia 
verruc iformis  les ions  are also reported in renal transplant rec ipients  
and these les ions  are more prone for  the development of  Bow ens 
disease,  squamous and basal c ell c arc inomas  in an 
immunocompromised background.66  
The HPV types  caus ing c ommon w arts  are mainly 2 and 4 and 
less  commonly 1 and 3.67 Human papilloma virus types 6, 11,  16 & 
18 are usually involved in ano-genital warts and squamous c ell 
carc inoma of the vulva.68  
BACTERIAL INFECTION  
Bac terial infections  of  skin are more c ommon in renal 
transplant individuals  and the prevalence is  higher in tropic al and 
subtropical regions.  The bacterial f lora of persons w ho underw ent 
transplant is  s imilar  to normal individuals and there is  no increased 
r isk of carr iage of pathogenic bacterias.98  
The most common organisms  caus ing bacterial infec tion are 
group A streptococc i and s taphylococcus  aureus,  which are s imilar 
to normal subjects,  and in c ases  of  c ellulitis,  there is  a poss ibility of 
occurrence of  unusual pathogens  like Cryptococcus  neoformans  and 
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candida spp. due to altered cell mediated immunity induced by 
immunosuppress ive agents.98  
In transplant individuals, bacterial infec tions  may manifest in 
various forms like impetigo,  follic ulitis,  furunc les, abscesses, 
cellulitis  and erys ipelas,  and the les ions  may produce more severe 
illness  and protracted c ourse than usual.97  Cutaneous  les ions  in 
renal transplant rec ipients  may occur as  unfamiliar  c linic al 
presentations  like cellulitis  w ithout inflammation and erythema, 
folliculitis  and furunculos is  resulting in pers istent and destructive 
ulcerations.97   
NOCARDIOSIS 
Noc ardios is  is  a rare but life threatening opportunistic 
infection,  espec ially in immunocompromised persons,  inc luding 
transplant individuals, neutropenic  patients  and on chronic 
corticos teroid therapy.  Noc ardios is  occurs  as  early as  one month 
after the immunosuppress ive therapy.34  
The most common c linic al presentation is  primary pulmonary 
infection,  but rarely disseminated noc ardios is  involves  skin,  central 
nervous  sys tem and cardiovascular  system in renal transplant 
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rec ipients.  Skin les ions  may present as  multiple abscesses, 
nodulopustules w ith cellulitis and chronic suppurative les ions.8  
MYCOBACTERIA 
Atypic al mycobacterial infections  rarely manifest in renal 
transplant patients and the skin les ions  may have diverse 
morphologies  like verrucous,  hyperkeratotic  papules,  subcutaneous 
absc esses  and nodules  and ulc erations. The commonly isolated 
organisms  are Mycobacterium marinum69  and Mycobacterium 
chelonae.70  
PARASITIC INFESTATIONS 
CRUSTED SCABIES 
Norw egian or  crusted scabies  is  a less  c ommon,  but severe 
infection c aused by mass ive infestation w ith Sarcoptes  scabiei var. 
hominis.  The drug induced suppress ion of  c ell mediated immunity 
increases  the r isk for  acquir ing the crus ted sc abies  in transplant 
rec ipients.  Crus ted scabies  usually manifes ts as crusted and 
hyperkeratotic plaques or  nodules whic h commonly involves 
extremities.  These eruptions  are less  pruritic,  and the burrows  and 
erythematous  papules  may be limited,  absent or  obsc ured by thick 
crus t.30  
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TUMOURS 
The prolonged period of  immunosuppress ive therapy used to 
preserve the allograft in renal transplant rec ipients  plays an 
important role in development of cutaneous malignanc ies.  
INCIDENCE OF TUMOURS 
In the general population,  the most c ommon tumors  are 
carc inoma of the skin,  lung,  pros tate,  female breast,  colon and 
rectum.  A markedly different pattern of  tumor development is  seen 
in organ transplant rec ipients.  Skin and lip c ancers  are more 
frequent than in the general population,  but their  inc idence varies 
w ith the amount of exposure to sunlight.33  
Certain malignanc ies  that are rare in the general population 
occur relatively common in organ transplant rec ipients. There is  a 
400 fold to 500 fold increase in the inc idence of  kapos i’s  sarcoma 
in renal transplant rec ipients  compared w ith c ontrols  of  the same 
ethnic origin.72  
Skin tumors occurs  in relatively younger group of  people 
whose average age at the time of transplantation was  40 years. The 
sex ratio of  male to female patient is  2:1.  In contrast w ith other 
known oncogenic  stimuli in humans  whic h often take 15 to 20 years 
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or  more before they c ause c linic al les ions,  c anc ers  presented in a 
relatively short time after transplantation.71  
ETIOLOGY OF TUMORS 
Depressed immunity results  in impairment of  body’s  ability 
to cope w ith c anc ers  caused by various  carc inogens  suc h as  sunlight 
and onc ogenic  viruses.  Infection w ith potentially oncogenic viruses 
are common in immunosuppressd patients.  Eps tein-barr  virus 
infection may contr ibute to the development of  non-hodgkins 
lymphomas.64  Papilloma virus  infec tions  may be involved in 
carc inoma of c ervix,  vulva,  perineum and skin.31  Human herpes 
virus 8 may contr ibute to the development of kapos i’s sarcoma.73  
BASAL AND SQUAMOUS CELL CARCINOMA  
Basal cell c arc inomas  outnumber squamous  cell c arc inomas 
in the general population,  but the oppos ite is  true in the transplant 
rec ipients  in whom squamous  cell c arc inoma outnumber basal c ell 
carc inoma by 2:1.33  In the general population,  these types  of  skin 
cancer occur mos tly in people in their 60s  and 70s,  but the average 
age of affected transplant patients is 30 years younger.33  
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SQUAMOUS CELL CARCINOMA (SCC) 
Squamous  c ell c arc inoma arises  from atypical keratinocytes 
of  the epidermis.  It occurs  mos t commonly in sun exposed areas 
and is  usually assoc iated w ith precursor les ions  like actinic 
keratoses,  Bowen’s  disease (SCC in s itu),  viral w arts  and/or 
keratoacanthomas.  The r isk of  SCC is  60 to 100 times  greater  than 
in the general population.74  
The pathogenes is  is  multifactorial,  w ith c umulative sun 
exposure as  most important factor.  Also infection w ith human 
papillomavirus  (HPV,  particularly oncogenic  HPV 5 and 8 s trains) 
plays  an important role in the development of  SCC, w ith HPV 
being detected in 65 to 90% of SCC of transplant rec ipients.68  Other 
r isk factors  are fair  skin,  age,  the level of  immunosuppress ion, 
duration of  pretransplantion dialys is,  ionizing radiation,  chronic 
inflamed skin ( like sc ars or c hronic ulc ers) and poss ibly smoking.72  
SCC is  more aggress ive in transplant rec ipients  than in the 
general population,  resulting in higher r isk of local recurrence 
(14% of patients),  regional and distant metastas is  (6-9% of 
patients) and mortality.71  
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BASAL CELL CARCINOMA (BCC) 
Basal cell c arc inoma arises  from the basal layer  of  the 
epidermis  and its  appendages.  I t occurs  on sun-exposed skin,  most 
commonly on the face or  head (up to 70%).  Common s ites  are 
eyelid margins, nose folds, lips and around and behind the ears.74  
The inc idenc e of  BCC is  increased by a factor  10 to 16 in 
transplant rec ipients,  c ompared to the general population.  Intense 
intermittent sun exposure is  important in the pathogenes is  of  BCC, 
in c ontras t w ith SCC where the cumulative sun exposure plays an 
important role.72  
MELIGNANT MELANOMA 
Malignant melanomas  arise from melanocytes.  To detect a 
malignant melanoma,  new  or changing pigmented les ions  should be 
examined w ith spec ial attention for  A.  assymmetry; B.  border 
irregularity; C. c olor variation/dark black color; D. diameter  more 
than 6 mm; and E, evolution or change.75  
Malignant melanomas  are c lass if ied into lentigo malignant 
melanomas  (aris ing on sun-exposed skin of  older  individuals), 
superfic ial spreading malignant melanomas  (most c ommon, 
occurring in 70%,  espec ially in Caucas ian people),  nodular 
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malignant melanomas,  acral lentiginous  melanomas  (aris ing on 
palms,  soles  and nail beds,  commonly in more darkly pigmented 
persons) and malignant melanomas on mucous membranes.75 
The r isk of  developing melanoma is  3.6 times  greater  in renal 
transplant rec ipients  than in the general population.72 Risk factors 
for  the development of  pos t transplant malignant melanomas  are the 
presence of  atypic al nevi,  history of  blister ing sunburns, 
immunosuppress ion,  fair  skin,  a personal or  family history of 
malignant melanomas,  older  age at the time of  transplantation and 
the use of depleting anti- lymphocyte antibodies.72  
KAPOSI’S SARCOMA (KS) 
 Kapos i’s sarcoma is  a vascular  neoplasm,  characterized by 
reddish-brown or purple-blue plaques  or  nodules  on cutaneous  or 
mucosal surfaces,  inc luding the skin,  lungs,  gastrointestinal tract 
and lymphoid tissue.  KS has  been assoc iated w ith the reactivation 
of  latent human herpes  virus  8 (HHV-8) infection or  donor-to-
rec ipient transfer of HHV-8 infected progenitor cells.32    
Kapos i’s  sarcoma makes  up 62% of post- transplant 
malignanc ies  in comparis ion w ith its  inc idence in the general 
population w here it constitutes only 0.02% to 0.07% of all 
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cancers.72  Sixty perc ent had non visc eral kapos i’s  sarcoma c onfined 
to the skin,  conjunctiva, oropharyngeal mucosa and 40% had 
visceral disease affecting mainly the GIT and lungs.73  
The increased inc idence of  kapos i’s  sarcoma in renal 
transplant rec ipients  may be attr ibuted to their  genetic  background 
along w ith immunosuppress ion and c oncomittent viral infec tion.32   
NON – HODGKINS LYMPHOMA 
Lymphoma account for  3% to 4% of tumors  in the community 
but c ons titute 14% of all tumors  in transplant patients.  The majority 
(97%) of  lymphoma w ere non-hodgkin’s  lymphoma,  whereas 
hodgkin’s lymphoma is  the most common lymphoma seen in the 
same age group of general population.71  
Post transplant non-hodgkins  lymphomas  differ  from their 
counterpart in the general population in several aspects.  The 
extranodal involvement occurs  24% to 48% of patients  w ith non-
hodgkin’s lymphoma,  whereas  it is  present in 73% of transplant 
patients  w ith non-hodgkin’s  lymphoma.  In the general population 
about 1% of non-hodgkin’s  lymphoma affect the brain parenchyma, 
whereas  in organ transplant patients  32% involves  the CNS usually 
brain parenchyma.78  
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MISCELLANEOUS DISORDERS 
SEBORRHEIC KERATOSIS  
These are benign w arty growths  w ith various  morphologic al 
patterns  commonly seen in immunocompetent individuals  w ith 
increas ing age and may also observed in renal transplant rec ipients, 
but the inc idence is  unc lear.  However,  there could be a confus ion 
w ith dysplastic  les ions  and a poss ible assoc iation w ith non-
melanoma skin cancer may be present.99  
SKIN TAGS 
Skin tags are pedunculated benign les ions that vary in s ize 
and commonly seen along w ith seborrheic  keratos is.  Euvrard and 
colleagues  reported multiple minute skin tags  on the neck and 
axillary folds of 5.5% paediatr ic transplant population.100  
SOLAR KERATOSIS 
Solar  keratos is  may appear 2 to 6 months  after 
transplantation.  The les ions  c linic ally present as loc alized adherent 
thickening of  skin w ith yellow ish hue on sun exposed regions.  In 
transplant rec ipients,  solar  keratos is  occurs  as multiple les ions 
whic h tend to recur after c onservative treatment and rapidly evolve 
into squamous  cell carc inoma but in immunocompetent persons  it 
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has  low  malignant   potential and prolonged latency to develop 
squamous cell c arc inoma.85  
POROKERATOSIS 
This  is  an unusual c ondition but its  variant disseminated 
superfic ial ac tinic  porokeratos is  (DSAP) has  been repeatedly 
described in transplant patients  and other  immunosuppresssed 
individuals.76  DSAP  c linic ally manifes ts  as  multiple small 
irregularly shaped thread like r ing les ions  w ith more predilection 
for lower limbs.77  
DRUG EFFECTS 
Patients  who are immunosuppressed for long term prevention 
of allograft rejection or  who are rec eiving prolonged therapy w ith 
cytotoxic  or  immunosuppress ive agents  are subjected to many 
pharmacological complic ations.  The types  and prevalence of  certain 
infections,  malignanc ies  and drug s ide effects  may depend on the 
spec if ic immunosuppress ive regimen used.83  
CORTICOSTEROIDS 
Corticos teroid in c ombination w ith cyc losporine or  cytotoxic 
agent are used in most immunosuppress ive protocols.  Steroid 
related cutaneous s ide effects  are almos t alw ays  present to some 
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degree during the f irst few  months  after  transplantation but become 
less prominent as maintenance dosages are tapered to lower levels.4  
Spec if ic  cutaneous  manifestations  that have been described in 
kidney transplant rec ipients  inc lude skin fragility w ith ecchymoses 
and purpura (Batemans  purpura),  violac eous str iae may be 
prominent espec ially in the axillae and groins.36  Steroid ac ne 
commonly occurs  on the trunk and extremities  as  small follicular 
papules  and pustules  usually at the same stage of  development 
w ithout c omedones.91  Severe form of acne like deep seated 
inflammatory nodulocystic  les ions have also been reported.  The 
androgen mediated stimulation of  pilosebaceous  unit is  the 
postulated theory for  the development of  steroid ac ne and hirsutism 
in patients w ho were treated w ith corticosteroid.92  
The perioral dermatitis  is  observed in transplant rec ipients 
receiving sys temic  s teroids  whic h c linic ally presents  as  redness  and 
papulopustules  around the mouth and nose.93  Other s ide effect of 
steroids inc lude, c ushingoid fac ies, telangiectases,  abnormal fat 
distr ibution (Buffalo hump),  acanthos is  nigricans,  atrophy, 
impaired wound healing,  generalized xeros is,  keratos is  pilar is  and 
alopec ia of the scalp.35  
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 AZATHIOPRINE 
Azathioprine is  a purine analogue derived from 
merc aptopurine that is  w idely used as  a immunosuppress ive agent. 
The mechanism of action in immunosuppress ion is  complex and 
involves  non spec if ic  suppress ion of  humoral  immune responses 
and delayed hypersens itivity.  Azathioprine is  indic ated as  an 
adjuvant for the prevention of  graft rejection after  renal 
transplantation.83  
Primary c utaneous c omplic ations attr ibutable to azathioprine 
are exc eedingly rare.  There are no reported inc idences  of 
hypersens itivity.  Azathioprine is  thought to be c o-oncogenic  in the 
development of  cutaneous  and sys temic  malignanc ies.  They act by 
enhanc ing the tumorogenic effects of other carc inogen.74  
In renal transplant rec ipients,  azathioprine along w ith an 
added effect of  undue exposure to ultraviolet light increases  the r isk 
of  developing kapos i’s  sarcoma.  In immunosuppressed patients  the 
les ion of  kapos i’s  sarcoma appear from three months  to four years 
after  the onset of  therapy.  Discontinuation of  immunosuppress ive 
agents  particularly azathioprine results  in regress ion of  tumour in 
some but not all patients.73  
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CYCLOSPORINE 
This  lipophilic  c yc lic  polypeptide w ith II  aminoac ids  is 
derived from the fungus  Tolypoc ladium inflatum gams.  This  drug 
selectively inhibits  T lymphocyte proliferation by inhibiting 
cyc lophillin-calc ineurin complex w ith a major effect on helper T 
cells  and may favour graft acc eptance by expans ion of  antigen 
spec if ic suppressor T cells. The use of  cyc losporine has  markedly 
improved the graft survival and commonly used in renal transplant 
patients.37  
Thirty to seventy percent of  the patients  receiving 
cyc losporine suffer  from hypertr ichos is  c harac terized by thick and 
pigmented hair  appearing over the trunk,  back,  shoulder,  arms, 
neck, forehead, helic es and malar region.36  
Ac ne, folliculitis,  sebac eous  hyperplas ia, epidermal c ysts  and 
keratos is  pilar is  have been reported in 10 to 20% of patients  treated 
w ith cyc losporine.35 ,82 Although some les ions may occur w ith 
corticos teroid adminis tration,  c yc losporine appears  to have a 
profound effect on the pilosebac eous  unit.  This  may be due to the 
fact that the drug is  highly lipophilic  resulting in accumulation in 
fat and sebaceous glands.37  
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Gum hyperplas ia occurs  in about one third of  transplant 
patients treated w ith cyc losporine.88  This complic ation generally 
occurs  after  3 or  months  of  treatment and c an be worsened by the 
concomitant administration of  calc ium channel blockers  or 
phenytoin.82  Skin hyperpigmentation and bullous or  vegetative 
les ions have also been reported in c yc losporine treated patients.88  
TACROLIMUS (FK 506) 
Tacrolimus is also an calc ineurin inhibitor w hich ac ts 
primarily by inhibiting proliferation of  T helper  c ells.  In contrast to 
cyc losporine,  the mucocutaneous  s ide effects  such as  gingival 
hypertrophy and hirsutism are less  commonly observed in 
Tacrolimus.89  The other  adverse effects  inc ludes  pruritus,  ves ic ulo 
bullous les ions, alopec ia, nephrotoxic ity and metabolic effects.90  
MYCOPHENOLATE MOFETIL (MMF) 
MMF derived from penic illium spec ies  and it affects  the de 
novo pathway of purine synthes is  by inhibiting inos ine 
monophosphate dehydrogenase enzyme.  
I t has  less  inc idenc e of  cutaneous  s ide effects  w hen compared 
w ith azathioprine but there is  an inc reased susceptibility to herpes 
s implex and zoster and cytomegalovirus infections.86,87  
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AIM OF THE STUDY 
1. To s tudy the prevalenc e of  cutaneous  diseases  in Renal 
Transplant   Rec ipients  
2. To study the various dermatos is in Renal Transplant Rec ipients  
3. To study the inc idence and types  of  cutaneous  infections  in 
Renal Transplant Rec ipients  
4. To study the cutaneous  s ide effects of  immunosuppress ive drugs 
in Renal Transplant Rec ipients  
5. To c orrelate the duration of  the immunosuppress ive therapy that 
predisposed to various  dermatos is  in Renal Transplant 
Rec ipients  
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MATERIALS AND METHODS 
This  study spanned a course of  one year  from Dec ember  
2012 to November  2012.  During this  period,  80 renal transplant 
rec ipients  on sys temic  immunosuppress ive therapy attending the 
Department of Nephrology and Dermatology were screened.  
The detailed history of  each patient was  noted w ith reference 
to age and sex, symptomatology and duration of  skin 
manifestations, dose and duration of immunosuppress ive agents, 
date of transplantation and family history of s imilar les ions.  
The patients w ere examined thoroughly for  all cutaneous 
manifestations.  The duration of  the cutaneous  les ions,  the s ize and 
extent of  involvement were noted.  In patients w ith dermatophytos is 
the morphology of  les ion w ith reference to presenc e of 
inflammation,  well defined or  illdefined margin and central 
c learance w ere recorded.  Those patients  in whom the infection 
lasted for  more than one year  inspite of  adequate  treatment w ere 
c lass if ied as cases of chronic dermatophytos is.  
All the patients  were subjected to routine hematologic 
investigations  like c omplete haemogram,  standard biochemic al 
 40 
investigations  like blood sugar,  blood urea,  serum creatinine,  serum 
electrolytes, c alc ium and phosphate levels.  Detailed urine 
examination was  carr ied out in all of  them.  Screening for  HIV w as 
also done in all the renal transplant rec ipients.  
Myc ologic al investigations  in c ases  of  fungal infections 
inc luded microscopic  examination of  skin scales,  muc osal scraping, 
pus  and touch smear from skin biopsy were done after  adding 10% 
Potass ium hydroxide (KOH) solution.  Nail scraping material w as 
examined under light microscopy after  adding 40% KOH in 
suspected cases of onchyomycos is.  
Gram stain and Ziehl Nielson stain were done in all suspected 
cases  of  cutaneous infection. Tzanc k smear was  done in ves iculo-
bullous  skin les ions.  In w illing patients,  skin biopsy was  done and 
the spec imens  were stained w ith haemotoxylin and eos in (H&E) 
and in required cases spec ial stains like Periodic-ac id Schiff  (PAS) 
Gomori’s  methenamine s ilver  (GMS) w ere used to confirm the 
diagnos is.  
Appropriate treatment was  given for  all the renal transplant 
patients presented w ith cutaneous les ions.    
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OBSERVATIONS AND RESULTS  
The total number of  renal transplant rec ipients  screened w ere 
80,  of  w hom 64 (80%) were males  and 16 (20%) w ere females  w ith 
the male to female ratio of 4:1.  
The age of  these patients  ranged from 16 years  to 55 years 
w ith an average of  33.2 years.  The age of  the youngest male patient 
in this  study was  16 years,  while the younges t female w as  18 years. 
Oldes t male was  55 years ,  where as the oldest female in this  study 
was 42 years.  
TABLE 1: AGE AND SEX DISTRIBUTION OF THE 
PATIENTS IN THE STUDY GROUP 
Se x distribution Age group 
ye ars  Male  Female  
Total numbe rs  pe rcentage 
10 – 20 02 01 03 3.75% 
20 – 30 22 10 32 40% 
30 – 40 26 04 30 37.50% 
40 – 50 10 01 11 13.75% 
50 – 60 04 -  04 5% 
Total 64 16 80 100% 
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In the age group of  20 to 30 years,  the maximum number of 
patients presented w ith cutaneous  manifes tations  were 32 (40%). 
The maximum number of  male patients  in the age group of  30 to 40 
years  were 26 (40.6%) and maximum number of  female patients 
were 10 (62.5%) in the age group of 20 to 30years.  
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PREVALENCE OF SKIN MANIFESTATIONS IN RENAL 
TRANSPLANT RECIPIENTS 
In this  s tudy,  out of  the 80 renal transplant rec ipients 
screened for  skin manifes tations,  70 patients  (87.5%) presented 
w ith fungal infection.  This  w as  followed by drug induced changes 
in 53 patients  (66.25%),  viral infections  in 23 patients  (28.75%) 
and bacterial infections  in 15 patients  (18.75%).  Misc ellaneous 
cutaneous les ions were encountered in 5 patients (6.25%).  
TABLE 2: VARIOUS SKIN MANIFESTATIONS IN RENAL 
TRANSPLANT RECIPIENTS ALONG WITH SEX 
DISTRIBUTION 
No.  Skin manifestation Male  Female  Total pe rcentage 
1 Fungal infection 61 09 70 87.50% 
2 Drug induced changes  42 11 53 66.25% 
3 Viral infection 19 04 23 28.75% 
4 Bac terial infection 12 03 15 18.75% 
5 Misc ellaneous  04 01 05 6.25% 
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Various skin manifestations in renal transplant recipients along 
with the sex distribution
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DURATION AND DRUG REGIMENS USED FOR 
IMMUNOSUPPRESSIVE THERAPY 
The duration of immunosuppress ive therapy follow ing 
transplantation among the study group ranged from 2 months to 7 
years.  Various  drug regimens  has  been used to induce 
immunsuppress ion to prevent graft rejection. The commonly used 
combination of drugs were cyclosporine(CSA), azathioprine (AZA) 
and prednisolone (PDN) in 49 patients  (61.25%),  follow ed by 
tacrolimus,  mycophenolate mofetil and prednisolone combination 
in 16 patients  (20%).  In patients  who were on prolonged period of 
immunosuppress ion,  the maintainenace drug c ombination  used 
were  either  prednisolone w ith azathioprine in 4 patients  (5%) or 
prednisolone w ith mycophenolate mofetil  in 3 patients (3.75%).  
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TABLE 3: DRUG REGIMENS USED FOR 
IMMUNOSUPPERESION 
No.  Drug combination No. of patients  Percentage  
1 CSA + AZA + PDN 49 61.25% 
2 TAC + MMF + PDN 16 20% 
3 CSA + MMF + PDN 08 10% 
4 AZA + PDN 04 5% 
5 MMF + PDN 03 3.75% 
Cyc losporine (CSA),   Azathioprine (AZA), Prednisolone 
(PDN),  Tacrolimus  (TAC),  Mycophenolate Mofetil (MMF), 
Prednisolone (PDN) 
Drug regimens used for immunosuppe resion
49
16
8
4 3
CSA + AZA + PDN
TAC + MMF + PDN
CSA + MMF + PDN
AZA  + PDN
MMF + PDN
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POST TRANSPLANT INTERVAL FOR SKIN 
MANIFESTATION 
Cutaneous  manifestations  w ere seen predominantly during the 
initial one year  of  post transplant period.  The most c ommon 
manifestation w as cutaneous infections,  of whic h  fungal infections 
were c ommonly seen and particularly during the 7 – 12 months  of 
post transplant period.  The viral infections  w ere more c ommonly 
manifested during the 1-2 years  of  post transplant period.  The 
bacterial infections  were commonly seen during the initial 6 months 
of  post transplantation.  Cutaneous  c hanges  due to drugs  w ere 
commonly observed during the f irs t year  of  post transplantion,  af ter 
whic h the inc idence w as gradually dec lined.   
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TABLE 4: POST TRANSPLANT INTERVAL FOR SKIN 
MANIFESTATION 
S. 
No. Skin manifestation 
0-6 
months 
7-12 
months 
13-24 
months 
25-60 
months 
> 60 
months 
Fungal infection 08 40 18 03 01 
a.Dermatophytosis - 12 12 02 - 
b.Pityriasis 
versicolor 
04 24 05 - - 
c.candidiasis 04 02 - - - 
1 
d.phaeohypomycosis - 01 01 02 01 
2 Drug induced 
changes 
18 23 12 - - 
Viral infection 05 07 07 04 - 
a.Human papilloma 
virus 
- 01 03 04 - 
b.Herpes zoster 01 04 04 - - 
3 
c. Herpes simplex 03 - - - - 
4 Bacterial infection 06 05 04 - - 
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Post transplant interval for fungal infection
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FUNGAL INFECTION IN RENAL TRANSPLANT 
RECIPIENTS 
Out of  80 patients  s tudied,  fungal infections  were seen in 70 
patients  giving an inc idence of  87.5%.  Of them 61 were male 
(88.4%) and 9 were females  (11.5%).  Their  age ranged from 16 
years  to 55 years w ith an average of 24.5 years  . Among the fungal 
infections  pityrias is  vers ic olor   les ions  w ere commonly encountered 
in 33 patients (47.14%), follow ed by dermatophytos is in 26 paients 
(37.14%),  c andidias is   in 6 patients  (8.5%) and phaeohypomycos is 
in 5 patients (7.1%).  
TABLE 5: PREVALENCE OF FUNGAL INFECTION ALONG 
WITH SEX DISTRIBUTION IN RENAL TRANSPLANT 
RECIPIENTS 
No.  Fungal infection Male  Female  Total Percentage  
1 Dermatophytos is  26 07 33 47.14% 
2 Pityrias is vers icolor  26 00 26 37.14% 
3 Candidias is  04 02 06 8.5% 
4 Phaeohypomycos is  05 00 05 7.1% 
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Prevalence of Fungal infection along with the sex distribution 
in renal transplant recipients
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PITYRIASIS VERSICOLOR 
Out of  70 patients  w ith fungal infection,  pityrias is  vers icolor 
les ions  w ere seen in  33 patients  w ith the inc idenc e of  47.14%.  Of 
these 26 (78.7%) w ere  males  and 7 (21.21%) were females.  The 
age of  these patients  ranged from 16 years  to 46 years  w ith an 
average of  29.48 years.  Pityrias is  vers ic olor  les ions  w ere commonly 
observed during the 7 to 12 months of post transplant period.  
The commonest morphologic  type of  pityrias is  vers icolor 
noted in this  study was  achromic  type (87.8%) distr ibuted in usual 
s ites  like c hes t and upper back.  The extent of involvement ranged 
from 3% to 70% of body surfac e area w ith an average of  17.1%. 
The patient w ith 70% area involvement was  a 24 year  old male who 
was  on cyc losporine,  azathioprine and prednisolone for  a period of 
15 months.  
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TABLE 6: AGE DISTRIBUTION IN RELATION TO 
CLINICAL MORPHOLOGY OF PITYRIASIS VERSICOLOR 
Age group (in ye ars)  
No. Clinical morphology 10-
20 
20-
30 
30-
40 
40-
50 
Total Percentage 
1 Ac hromic  2 17 6 4 29 87.87% 
2 Chromic  1 6 2 1 10 30.30% 
3 Usual s ite 3 17 5 4 29 87.87% 
4 Unusual s ite 0 3 2 1 6 18.18% 
Usual site: Face, chest and upper back. Unusual site: forearm and thigh. 
Out of 33 patients  w ith pityrias is vers ic olor  les ions, 13 
patients had assoc iated dermatophytos is, two patients  had herpes 
labialis,  one post- transplant diabetic  patient had c andidial intertr igo 
groin and one patient had verruca vulgaris.   
Microscopic  examination of the scales  in 10% in KOH 
showed short,  angulated,  aseptate hyphae w ith group of  spores  and 
blastospores in all the 33 patients.  
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DERMATOPHY TOSIS 
Among the 70 renal transplant rec ipients  w ith fungal 
infection,  dermatophytos is  was  observed in 26 (37.14%) patients. 
All of them were males.  
Among the various c linic al types of  dermatophytos is,  tinea 
cruris  was  the commonest type (76.9%) follow ed by tinea c orporis 
(69.2%),  tinea glutealis  (46.1%),  tinea manuum (26.9%),  tinea 
fac iei (19.2%), tinea pedis (15.3%) and tinea unguium (15.3%).  
TABLE 7: AGE INCIDENCE IN RELATION TO CLINICAL 
TYPES OF DERMATOPHYTOSIS 
No. Clinical types  
20-
30yrs  
30-
40yrs  
40-
50yrs  Total Percentage 
1 Tinea cruris  7 10 3 20 76.9% 
2 Tinea 
corporis  
6 9 3 18 69.2% 
3 Tinea fac iei 2 2 1 5 19.2% 
4 Tinea 
barbae 
1 1 0 2 7.6% 
5 Tinea 
manuum 
2 3 2 7 26.9% 
6 Tinea 
glutealis  
2 8 2 12 46.1% 
7 Tinea pedis  1 2 1 4 15.3% 
8 Tinea 
unguium 
1 3 0 4 15.3% 
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Dermatophytos is  was  most commonly seen in the age group 
of  30-40 years.  It w as c ommonly seen 7 months  after  the 
transplantation and out of  26 patients  w ith dermatophytos is, 24 
patients  (92.3%) were developed les ions  the w ithin 24 months  of 
transplantation. The occurrenc e of  dermatophytos is  in relation w ith 
age w as  betw een 23 to 46 years  and the mean age was  about 32 
years.  
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TABLE 8:  CLINICAL MORPHOLOGY OF THE 
DERMATOPHY TOSIS IN RENAL TRANSPLANT 
RECIPIENTS 
No.  Morphology of the 
lesion 
Total Percentage  
1 Inflammatory 8 30.7% 
2 Non - inflammatory 22 80.7% 
3 Well - defined 8 30.7% 
4 I ll – defined 24 92.3% 
5 Hypopigmented 20 76.9% 
6 Hyperpigmented 7 26.9% 
7 With central c learanc e 9 34.6% 
8 Without c entral 
c learance 
22 80.7% 
The commonest morphology in dermatophyte infection 
observed was  non-inflammatory type (80.7%),  in majority of 
patients  w ith ill-defined margins  (92.3%),  of  which most of  the 
les ions  showed hypopigmentation (76.9%) and absence of  central 
c learance (80.7%).  Well-defined inflammatory les ions  w ere about 
30.7%,  of  whic h 26.9% les ions  showed hyperpigmentation.  Out of 
26 patients w ith dermatophytos is  11 (42.3%) patients  had chronic 
dermatophytos is.  
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Among the 26 patients  w ith dermatophytos is,  13 patients  had 
coexistent pityrias is vers icolor les ions. 
The scales  were obtained by gently scraping the les ions  and 
then examined under light mic roscopy after  adding 10% KOH  
whic h revealed hyaline,  long, branching septate hyphae w ith 
arthrospores in all the 26 patients.  
Clinical Morphology of the dermatophytosis in renal transplant 
recipients
8
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TINEA UNGUIUM IN RENAL TRANSPLANT PATIENTS 
Out of  26 patients  w ith dermatophytos is  in this  study,  tinea 
unguium w as  observed in 4 patients  giving an inc idence of  15.38%. 
The duration of  post transplant interval before the development of 
tinea unguium ranged from 12 months to 18 months. The 
involvement of  f inger nails  w ere commonly observed in 3 patients 
(75%) w hen compared to toe nails  involvement in 1 patient (25%). 
In all the four patients, dis tal and lateral subungual onyc homycos is 
type were observed.  
The subungual keratin in 40% KOH was  examined under light 
mic roscopy w hich revealed hyaline,  long,  branching septate hyphae 
w ith arthrospores in all the four patients.  
PREVALENCE OF CANDIDIASIS IN RENAL TRANSPLANT 
RECIPIENTS 
Among the 70 patients  w ith mycotic  infection,  s ix patients 
(8.5%) in toto had c andidias is,  of whom four were males (66.6%) 
and 2 (33.3%) were females.  Their  age ranged from 24 years  to 38 
years  w ith the mean of  31.8 years.  Candidias is  w as  commonly 
observed during initial 6 months of post transplant period.  
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TABLE 9: CLINICAL TYPES OF CANDIDIASIS IN 
RELATION TO AGE OF THE PATIENT 
Age in years  
No.  Clinical types  
20-30 30-40 
Total Percentage  
1 Oral candidias is  1 3 4 66.6% 
2 Intertr igo groin 1 1 2 33.3% 
3 Balanoposthitis  0 1 1 16.6% 
Oral c andidias is  were asymptomatic in all the 4 patients 
(66.6%),  but two patients w ith intertr igo groin 2 (33.3%) and one 
patient (16.6%)  w ith  balanoposthitis had symptoms of  itching and 
burning sensation.  Of the s ix patients  w ith candidias is,  3 patients 
had diabetes  mellitus  and one patient had pityrias is vers icolor.  The 
mic roscopic  examination of  greyish white material from mucosa 
after  adding 10% KOH showed budding yeast c ells  w ith 
pseudohyphae in all the s ix patients. 
Clinical types of candidiasis in relation to age of the patient
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PHAEOHYPOMYCOSIS 
Phaeohypomycos is  was  noted in 5 male patients (7.1%) and 
no females  w ere affected.  Age group ranged from 16 years  to 52 
years  w ith the mean of  36.6 years.  Four patients  were developed the 
les ion one year  after  the transplantation and one patient developed 
10 months  after the transplantation.  Vaious c linic al presentations 
like subcutaneous  cysts,  absc esses,  ulc eroproliferative growth and 
carbunc le like les ion w ere observed among the f ive patients.  
The seropurulent material obtained from the les ions  by 
aspiration or  touch smear of  biopsy spec imen in 10% KOH w as 
seen under light microscopy whic h revealed pigmented septate 
moniliform hyphae. Skin biopsy showed suppurative fungal 
granuloma in the dermis  and subcutaneous  tissue in haemotoxylin 
and eos in stained section.  Spec ial s taining w ith Periodic-ac id Schiff 
(PAS) and Gomori’s  methenamine s ilver  (GMS) showed 
moniliform fungal elements  whic h confirmed the diagnos is  of 
phaeohypomycos is in all the f ive patients.   
VIRAL INFECTION 
The total number of  patients  observed to have viral infections 
were 23 (28.75%),  of whom 19 were males  (82.6%) and 4 w ere 
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females  (17.3%). The age of  these patients  ranged from 21 years  to 
55 years  w ith an average of  36.5 years. Viral infections  were more 
commonly noted betw een 7 months  to 24 months  of pos t transplant 
period. The prevalence of various viral infections is given in table 10 
TABLE 10: PREVALENCE OF VIRAL INFECTION IN 
RELATION TO AGE OF THE PATIENT 
Age group in 
ye ars  No. Viral infe ction 
20-
30 
30-
40 
40-
55 
Total Percentage 
1 Verruc a vulgaris  3 2 3 8 34.78% 
2 Herpes s implex 2 1 0 3 13.04% 
3 Varicella 2 0 0 2 8.6% 
4 Herpes zoster  1 3 5 9 39.13% 
5 Molluscum 
contagiousm 
1 0 0 1 4.3% 
Prevalence of viral infection in relation to age group of the patient
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HERPES ZOSTER 
Herpes zoster was the commonest viral infection noted in this 
study group, as it was seen in 9 renal transplant patients (39.13%), out 
of 23 patients with viral infections. The les ions were seen in 8 
(88.8%) males and 1 (11.1%) female. Herpes zoster  les ions were seen 
commonly during the 7 to 24 months of post transplantation period. 
Two patients showed multidermatomal involvement and hemorrhagic 
les ions. These les ions were commonly noted in thorac ic dermatome in 
5 patients (55.5%) followed by cervical dermatome in 3 patients 
(33.3%) and lumbosacral region in one patient (11.1%). 
 Human Papilloma Virus (HPV) Infection 
HPV infec tion w as  the sec ond commonest type of  viral 
infection in this  study. Verruca vulgaris  les ions  were noted in 8 
patients (34.78%), out of  23 patients  w ith viral infections and the 
distr ibution of  les ions w ere mainly c onfined to the extremities. 
Among the 8 patients  w ith verruc a,  7 patients  w ere (87.5%) males 
and 1 female patient (12.5%).  These les ions w ere commonly 
observed one year after  the transplantation.  Out of  these 8 patients, 
tw o transplant patients  had assoc iated dermatophytos is  and one 
patient had pityrias is vers ic olor.  
 63 
Herpes Simplex Virus (HSV) Infection 
Infection w ith herpes  s implex virus  was  noted in 3 (13.04%) 
patients, of  whom 1(33.3%) w as male and 2 (66.6%) were females. 
All the three had herpes  labialis.  In this s tudy herpes  labialis w as 
commonly seen during initial 6 months  of pos t transplant period . 
In one patient,  les ions  became ulc erated and w as  pers is ted for  about 
one month duration and c ompletely healed after  oral ac yc lovir 
therapy.    
 Tzanck smear of  the ves icular  les ion show ed multinuc leated 
giant c ells.  Two patients  had assoc iated pityrias is vers icolor 
les ions.  
Chickenpox 
Varicella infection w as observed only in two male patients 
(8.6%),  w hich w ere seen during the initial four months  of 
transplantation. Among them one patient had disseminated les ions 
and the other  patient had few discrete dew drop ves ic les  over the 
neck. The tzanck smear showed multinuc leated giant cells.  
Molluscum contagiosum 
This  infection w as  observed in only one transplant patient 
(4.3%).  The les ions  w ere multiple,  dome shaped,  skin c oloured, 
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f irm,  umblic ated papules  w ith an express ible cheesy c ore and 
distr ibuted over the thigh.  Molluscum bodies  w ere demonstrated 
mic roscopic ally by us ing leishman s tain.  
BACTERIAL INFECTIONS 
Bac terial infections  w ere observed in 15 (18.75%) patients,  of 
whom 12 (80%) were males  and 3 (20%) were females.  The age of 
these patients  ranged from 26 years  to 43 years  w ith an average of 
34.6 years.  I t was  observed more c ommonly in f irst year  of  post 
transplantation .  In this  study most c ommon bacterial infection 
observed w as furunculos is  in 6 patients  (40%),  followed by 
impetigo in 4 patients  (26.6%) and cellulitis  in 1 patients  (13.3%). 
In a 43 year  old post transplant diabetic  patient both furunculos is 
and c ellulitis w ere observed.  The gram stain of  pus  material 
showed gram pos itive c occi in all the cases  of  furunculos is, 
impetigo and c ellulitis.  Erythrasma w as  noted in 4 patients  (26.6%) 
and the  diagnos is  w as  confirmed by c oral-red f lourescence in 
Wood’s lamp examination.  
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TABLE 11: PREVALENCE OF BACTERIAL INFECTION 
ALONG WITH AGE DISTRIBUTION IN RENAL 
TRANSPLANT RECIPIENTS 
Age in years  
No. Bacte rial infection 20-
30 
30-
40 
40-
50 
Total Percentage 
1 Furunculos is  1 3 2 6 40% 
2 Impetigo 2 1 1 4 26.6% 
3 Cellulitis  0 1 1 2 13.3% 
4 Erythrasma 1 2 1 4 26.6% 
 
SKIN MANIFESTATIONS DUE TO DRUGS IN RENAL 
TRANSPLANT RECIPIENTS  
Drug induced changes  were seen in 53 (66.25%) renal 
transplant patients,  of  w hom 42 w ere males  (  79.2%) and 11 w ere 
females  (20.7%).  Their  age ranged from 16 to 55 years w ith an 
average of  31.9 years.  The various  drug regimens  used to induce 
immunosuppress ion w as  shown in Table 3.  The c ommonly used 
regimen was  combination of  cyc losporine,  azathioprine and 
prednisolone in 49 (61.25%) patients,  follow ed by  combination of 
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tacrolimus,  mycophenolate mofetil and prednisolone in 16 (20%) 
transplant rec ipients.  
The c ommones t s ide effect observed w as  c ushingoid fac ies  in 
31 patients  (60.3%),  followed by s tr iae in 19 patients   (35.8%) and 
ac neiform eruptions  in 13 patients  (24.5%).  Hypertr ichos is  over the 
face,  chest,  upper arm,  and bac k w as observed in four patients 
(7.5%) and these patients  were on cyc losporine containing drug 
therapy.  Gum hyperplas ia w as  noted in f ive male patients   (9.4%), 
who were all had treatment w ith c yc losporine.  Three patients 
(5.6%) on c yc losporine developed hirsutism.  
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TABLE 12: SKIN MANIFESTATIONS DUE TO DRUGS IN 
RENAL TRANSPLANT RECIPIENTS ALONG WITH AGE 
AND SEX DISTRIBUTION 
No.  Skin changes Male  Female  Total Percentage  
1 Cushingoid fac ies  22 10 32 60.3% 
2 Ac neiform eruptions  10 03 13 24.5% 
3 Str iae 18 01 19 35.8% 
4 Hypertr ic hos is  04 -  040 7.5% 
5 Gum hyperplas is  05 -  05 9.4% 
6 Hirsutism -  03 03 9.6% 
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MISCELLANEOUS DISORDERS 
In this s tudy,  few miscellaneous  cutaneous  disorders w ere 
seen in f ive patients  (6.25%).  Keratos is  pilar is  was  seen in one 
male patient who was  on c yc losporine and prednisolone. 
Exaggerated insect bite allergy was  noted in one HIV negative 
female patient.  Fixed drug eruption w as  noted in one male patient 
and the probable drug w as  not known.  One female patient 
developed lic hen planus  two years  after  the transplantation.  A forty 
three year old male patient had c lass ic al sc abies.     
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DISCUSSION 
Renal transplant patients  may present w ith various  cutaneous 
les ions  during the post transplant period.  This  study has  been 
conducted to highlight the spectrum of skin les ions  seen in renal 
transplant rec ipients in a tropic al environment.  
The study results shows that infections  were the most 
common cutaneous  manifes tation in renal transplant rec ipients. 
Among the infections,  fungal infections  were the most c ommon 
(87.5%),  follow ed by viral (28.75%) and bacterial infections 
(18.75%).  These results  were s imilar  to the study conduc ted in 
India by Leni George et al in 2010,39  and  discordant w ith the study 
conducted in Tehran by  Ghaninejad  et al40 , which showed that 
viral infections (40%) were the commones t skin infection.  
In this s tudy,  among the fungal infections,  pityrias is 
vers ic olor  (47.14%) being the mos t common infection follow ed by 
dermatophytos is  (37.14%) and c andidias is  (8.5%).  The Leni George 
et al39  (36.5%),  Gulec  et al42  (36.3%)  and  Zamanian et al41 
(24.9%) studies  also showed that pityrias is  vers ic olor  was  the 
commonest  fungal infection.  
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The prevalenc e of  pityrias is  vers ic olor  is  higher in this  study 
when compared to other  studies  like Chugh et al43  (13.3%) and 
Koranda et al36  (18%).  
The pityrias is  vers icolor  les ions  were commonly notic ed 
during the initial one year  of   post transplant period.  The increased 
inc idence of  pityrias is  vers icolor  in renal transplant rec ipients 
could be attr ibuted to increased thic kening of horny layer of skin, 
delayed desquamation of s tratum c orneum,  overgrowth of 
Malassezia spp and myc elial shift due to immunosuppress ion and 
particularly w ith the use of sys temic steroids.79  
Dermatophytos is  being the second commones t fungal 
infection in this  study and the prevalence of dermatophytos is  w as 
about 37.14%, whic h was  s lightly low er than the study c onducted 
by Selvi et al,11  in which the prevalence of  42% was  reported.  In 
Leni George et al39 s tudy,  dermatophytos is  accounted for  only 10% 
of total skin les ions which gross ly differ from this study.  
All patients  affected by dermatophytos is  were males  and none 
of the female was  affected.  This could be attr ibuted to the large 
number of  males  were screened when compared w ith females. 
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However,  dermatophyte infection seems to be generally have less 
inc idence in females as observed in various studies conducted.11 ,45  
In this s tudy group dermatophyte infec tion frequently seen in 
7 to 24 months  of  post transplant period which were s imilar  to the 
results  of  Leni George et al39  study,  states  that dermatophytos is 
were c ommon in patients  w ith  pos t transplant period more than s ix 
months.   Out of  26 patients  w ith dermatophytos is  11 patients 
(42.3%) had c hronic  dermatophytos is  inspite of  adequate treatment. 
This  inc idenc e was  almost equal to the observation notic ed in Selvi 
et al study.11   
The high prevalenc e and c hronic ity of  the dermatophytos is 
observed in these patients  c ould be due to the constant 
immunosuppress ion induc ed by the immunosuppresants.  In 
addition,  increased thic kening of  the horny layer of  the skin and 
delayed desquamation of  stratum corneum induced by the action of 
sys temic  steroids  also plays s ignif ic ant role in the pers is tence of 
infection.46  
The commonest c linical type notic ed in this s tudy was  tinea 
cruris  (76.9%),  follow ed by tinea corporis  (69.2%) and tinea 
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glutealis  (46.1%).  These results  w ere c omparable w ith the study 
conducted by Selvi et al11.  
In the majority of  dermatophytos is  patients,  the les ions  w ere 
non-inflammatory w ith ill defined margin whic h w as  s imilar  to the 
results  obtained in Selvi et al s tudy.11  These type of  c linical les ions 
indic ate the diminished host response to dermatophyte infection.11  
Tinea unguium was  observed in 15.3% of patients  and the 
distal and lateral subungual (DLSO) type of c linic al presentation 
was  noted in all the patients.  The proximal subungual white 
onychomycos is (PSWO) type of  tinea unguium was  not seen in this 
study population but it w as  c ommonly noted in patients  on 
immunosuppress ion.11 ,15  
The inc idence of  candidias is  in this  study population w as 
(8.5%) and occurred commonly during the early (< 6 months)  phase 
of pos t transplant period.  These results  were s imilar  to the results 
of  various  studies  like Ghaninejad et al,40  Sandhune et al47  and 
Formic one et al.48  
Oral candidias is  was  the commones t c linic al presentation 
observed in this  s tudy population and pseudomembranous  gloss itis  
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was  noted in all the patients.  The candidial intertr igo manifested as 
mac eration,  glazed erythema and satellite pustular les ions. The 
diabetes  mellitus  may be an additional predispos ing factor  along 
w ith immunosuppress ive treatment in 3 c andidias is patients.  
The decreased inc idenc e of  c andidias is  in renal transplant 
rec ipients  compared to other  fungal infection could be attr ibuted to 
the factors  like prophylac tic  antifungal therapy and asymtomatic 
nature of  infection due to depressed immunity related dec eased 
inflammatory response.6  
In this  study phaeohypomycos is  w as  occurred in 7.1% of 
patients w ith different c linic al morphologic al patterns  like multiple 
cys ts,  abscesses,  ulc eroproliferative growth and carbunc le,  where as 
in Leni George et al39  study one patient had a phaeohypomycotic 
cys t. There are few case reports from India on the presence of 
phaeomycotic cysts in renal transplant rec ipients.56 -58  
Phaeohypomycos is  was  commonly seen in renal transplant 
patients w ith more than one year  of  post transplant period and 
prolonged immunosuppress ive therapy.21   
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Herpes zoster  (39.13%) was  the mos t c ommon viral infection 
observed in the study population.  Leni George et al39  study 
observed herpes  zos ter  only in 7.5% patients.  The 
immunosuppress ion induced reac tivation of  varicella-zos ter  virus 
occurred mainly betw een 7 to 24 months  of  pos t transplant period 
but according to Ghaninejad et al40  s tudy,  the zoster  les ions  w ere 
commonly noted in early post transplant period (< 6 months).  
Verruc a vulgaris  (34.78%) was  the sec ond commonest viral 
infection noted in this  study whic h is  almos t s imilar  to the results 
of the s tudy conducted by Ghaninejad et al40. In renal transplant 
patients the occurrence of  warts  increased w ith the duration of 
immune suppress ion rather  degree of  immunosuppress ion49  and 
frequently seen in  patients on post transplant immunosuppress ive 
therapy of more than one year duration.50  
In this  study the prevalence of  herpes  s implex infection w as 
(13.04%) w hich was  low er than the reported inc idenc e of 35% in 
Koranda et al36  study.  Herpes s implex virus  infections w ere 
substantially higher in the initial s ix months  of  post transplant 
period. In one patient,  les ions  became ulc erated and w as pers isted 
 75 
for  about one month duration and c ompletely healed after  oral 
ac yc lovir therapy.    
The prevalenc e of  bacterial infection in this s tudy was  18.7% 
and commonly manifes ted during the f irs t one year  of  post 
transplant period.  In this  s tudy,  the prevalenc e of   bacterial 
infection were little high when compared to Lugo-Janer et al46  – 
11%, Chugh et al – 8.9% and Barba et al51 – 3.5%.  
The commonest c utaneous  les ion caused by bacterial 
infection was  furunculos is  (40%) followed by impetigo (26.6%) 
and the results  (48.5%  and 30% respectively)  were comparable 
w ith Leni George et al39 study.   
The probable reasons  for  decreased prevalence of  bacterial 
infections  in renal transplant individuals  inc ludes  prolonged 
antibiotic therapy follow ing transplantation and w ell preserved B 
lymphocyte function.46   
Drug induced cutaneous  c hanges  w ere more c ommon in the 
initial one year of  post transplant period.  This  may be attr ibuted to 
the high dose of immunosuppress ive drugs used during the early 
phase of post transplantation when the r isk of rejection is higher.39  
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Cushingoid facies (60.3%) were observed to be the most 
common drug induced skin change, which is higher than the study 
results of Chugh et al (27.4%) 43 and Benc ini et al (32.7%).45  Striae 
(35.8%) was the second common drug induced cutaneous change 
observed in this study, but Leni George et al study shows only 3.9%. 
Acneiform eruptions (24.5%) were s ignif ic antly higher in 
patients whose post transplant duration was less than s ix months and 
the results (24.6%) were s imilar to Leni George et al study39 . These 
les ions were commonly observed with cyclosporine, azathioprine and 
prednis lone combination therapy because these drugs may act 
separately and/or synergistically on sebaceous gland.82 
The inc idenc e of  gum hyperplas ia was  found to be higher 
(6.25% vs  2.4%) and hypertr ic hos is  w as low er (5% vs  9.9%) when 
compared to Leni George et al study.39  and these changes  also 
commonly noted in patients treated w ith c yc losporine .82  
Keratos is pilar is was noted in one male patient in this study and 
could be due to steroid and cyclosporine therapy.35  In this study the 
drug induced changes showed a declining incidence as the 
transplantation interval lengthened as reported by Goldstein GD et al.54                      
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In this  study ,  c utaneous  malignanc ies  were not seen whic h is 
s imilar  to the observation by Leni George et al study done in south 
India39   and the inc idenc e of  skin malignanc ies  in Chugh et al43 
study were only 0.6%.  Various  other  studies  c onducted in European 
countr ies  showed that the inc idenc e of  skin cancer among kidney 
transplant individuals  varied from 8% at 1 year  to 44% at 15 
years.78  
The cumulative effec t of  viral infections, prolonged 
immunosuppress ion and UV exposure has  been thought to 
predispose renal transplant patients   for  the development of 
cutaneous malignanc ies.85   The increased level of  melanin52 and the 
pattern of  melanosmal dispers ion in individuals  w ith skin 
phototypes  V and VI are the important factors  in decreas ing the 
occurrence of  skin malignanc ies  by providing protection from the 
cutaneous  effects  of  UV radiation and hence a very low  inc idence 
of malignant skin les ions in Indian renal transplant rec ipients.53       
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CONCLUSION 
The prevalenc e of  skin les ions  in renal transplant rec ipients 
was  found to be high.  Among the screened patients,  most c ommon 
manifestation were fungal infections,  followed by drug induced 
cutaneous changes, viral infections and bacterial infections.  
The superfic ial fungal infections  like pityrias is  vers icolor, 
dermatophytos is  and candidias is  were commonly encountered,  of 
whic h pityrias is  vers icolor  w as  the c ommonest,  follow ed by 
dermatophytos is  .  The renal transplant rec ipients  could be 
cons idered as  a high r isk group for  the infection w ith malessezia  
and dermatophyte.  Candidias is  w as less  frequently seen in kidney 
transplant patients.  
There is  an increased inc idence of  phaeohypomycos is  in renal 
transplant patients on prolonged immunosuppress ion.  
Herpes  zos ter  and verruca vulgaris   w ere the commonest viral 
infections  seen in renal transplant patients.  Among the bacterial 
infections , the commonest was furunculos is follow ed by impetigo.  
In drug induced cutaneous c hanges,  cushingoid fac ies w ere 
commonly seen,  followed by s tr iae and ac neiform eruptions.  Gum 
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hyperplas ia and hypertr ichos is  were commonly seen in cyc losporine 
containing drug regimen.  
The drug induced c utaneous  changes w ere less c ommon after 
one year of pos t transplantation.    
        In the initial 6 months  of  post transplant period commonly 
observed cutaneous  manifes tations  w ere candidias is,  herpes 
labialis, c hickenpox , furunculos is and acneiform eruptions.  
Pityrias is  vers icolor  les ions  w ere frequently seen during the 7 
to 12 months of post transplant period.  
The dermatophytos is,  herpes  zos ter  and verruca vulgaris  w ere 
commonly manifes ted between 7 to 24 months  of  pos t transplant 
period.  
The antic ipation of  c ertain cutaneous  les ions  in the particular 
phase of  post transplant interval and early diagnos is  and treatment 
w ill improve the quality of life in renal transplant rec ipients.    
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 ORAL CANDIDIASIS 
 
10% KOH  
BUDDING YEAST CELLS WITH PSEUDOHYPHAE  
CANDIDA 
 
 CANDIDAL BALANOPOSTHITIS 
 
 
 
TINEA CORPORIS 
 
 TINEA GLUTEALIS 
 
 
CUSHINGOID FACIES WITH TINEA CORPORIS 
 
 10% KOH  
HYALINE BRANCHING SEPTATE HYPHAE WITH 
ARTHROSPORES  
DERMATOPHY TE 
 
 
DISTAL AND LATERAL SUBUNGUAL ONYCHOMYCOSIS 
 
 STRIAE WITH ACHROMIC PITYRIASIS VERSICOLOR 
 
PITYRIASIS VERSICOLOR  
UNCOMMON SITE 
 
 CHROMIC PITYRIASIS VERSICOLOR 
 
10% KOH  
SHORT ANGULATED ASEPTA TE HYPHAE WITH GROUP OF 
SPORES AND BLASTOSPORES  
MALESSEZIA 
 
 MULTIPLE ABCESS  
PHAEOHYPOMYCOSIS  
 
MULTIPLE ABCESS AND CYSTS   
PHAEOHYPOMYCOSIS 
 
 PHAEOHYPOMYCOTIC CYST 
 
ULCEROPROLIFERATIVE GROWTH  
PHAEOHYPOMYCOSIS 
 
 10% KOH  
SEPTATE MONILIFORM HYPHAE  
PHAEOHYPOMYCOSIS 
 
GOMORI’S METHENAMINE SILVER STAIN (GMS) 
MONILIFORM FUNGAL ELEMENTS   
PHAEOHYPOMYCOSIS 
 
 PERIODIC ACID SCHIFF STAIN (PAS) 
MONILIFORM FUNGAL ELEMENTS 
PHAEOHYPOMYCOSIS 
 
 
SCABIES 
 
 ERYTHRASMA 
 
WOODS LAMP  
CORAL RED FLOURESENC E  
ERYTHRASMA 
 
 FURUNC ULOSIS 
 
 
CHICKEN POX 
 
 MOLLUSCUM CONTAGIOUSM 
 
HERPES ZOSTER 
 
 TZANCK SMEAR  
MULTINUCLEA TED GIANT CELL  
 
HERPES LABIALIS 
 
 VERRUCA VULGARIS 
 
 
ACNEIFORM ERUPTIONS 
 
 GUM HYPERPLASIA 
 
FIXED DRUG ERUPTION 
PROFORMA 
CLINICAL STUDY OF CUTANEOUS MANIFESTATIONS IN 
RENAL TRANSPLANT RECIPIENTS 
Name                           Nephrology no 
Age                              Case no 
Sex 
Address  
Occ upation                   Marital s tatus  
Cause of renal failure 
Renal transplantation done on 
Duration of pos t transplantation period 
Duration of  immunosuppress ion before the development of  skin 
les ions     
Drugs  
COMPLAINTS REGARDING SKIN MANIFESTATIONS 
Dryness  
I tching 
Pigmentation 
Red spots  
Raised skin les ions  
Fluid f illed les ions  
Poor w ound healing 
Hair  changes 
Nail changes  
Any other changes 
CLINICAL EXAMINATION 
   Date of appearance Post transplant duration 
Skin changes      
Cushingoid 
Ac ne 
Fac ial erythema 
Atropy & dryskin 
Purpura 
Telangiectas ia 
Hyperpigmentation 
Bullous les ions 
Icthyos is  
Palms and Soles  
Hair  changes  
Nail changes  
INFECTION 
   Date of appearance         Post transplant duration 
Wart 
HSV 
Varicella 
Zoster  
MC 
Impetigo 
Furunculos is  
Cellulitis  
Erythrasma 
Sc abies  
 
FUNGAL INFECTIONS 
Dermatophytos is  
Tinea c apitis / T.Fac iei / T.Barbae/ 
T.Corporis / T.Cruris / T.Manuum/ 
T.Pedis / T.Unguium/ 
Clinical morphology 
Inflammatory/non inflammatory 
Well defined/ill defined 
Hypo or hyperpigmented/combined 
With or w ithout central c learanc e 
DEEP DERM ATOPHYTOSIS 
PITYRIASIS VERSICOLOR 
Chromic or Ac hromic  
Usual or Unusual s ite 
Surface area 
CANDIDIASIS 
Intertr igo/Paronychia/Onychia/ 
Oral Thrush/Perleche/Gloss itis/ 
Vulvovaginitis /Balanopos thitis  
OTHER MYCOSIS 
ORAL MUCOSA CHANGES 
Ulc eration 
Gum hyperplas ia 
Any other changes 
 
NAIL CHANGES 
Beau’s lines  
Mee’s lines  
Muehrcke’s lines  
Half  and half nail 
Terry’s nail 
Splinter haemorrhage 
Onycholys is  
HAIR CHANGES 
Alopec ia 
Thinning of hair  
Changes in colour 
Hypertr ic hos is  
Any other changes 
INVESTIGATIONS 
Hb% ,TC ,DC,ESR ,Platelet count 
Blood sugar,urea , Sr creatinine 
Liver function test 
Serum electrolytes, pottas ium, c alc ium 
Urine albumin,sugar,depos its 
Tzanck smear 
Gram stain 
AFB stain 
Scraping for fungus / Mite 
Nail c lipping and Hair root examination 
Fungal culture in SDPA/SDA 
Woods lamp study 
Skin biopsy 
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1 M 16 10 mon Y Y Y Y Y Y Y Y Y
2 M 17 8 mon Y Y Y Y Y Y
3 F 18 8 mon Y Y Y Y Y
4 M 21 12 mon Y Y Y Y Y
5 M 22 4 mon Y Y Y Y Y Y Y
6 M 23 10 mon Y Y Y Y Y Y Y Y
7 M 24 12 mon Y Y Y Y Y Y
8 M 24 15 mon Y Y Y Y Y Y Y Y Y
9 M 25 12 mon Y Y Y Y Y Y Y
10 M 25 4 mon Y Y Y Y Y Y
11 M 26 24 mon Y Y Y Y Y
12 M 26 6 mon Y Y Y Y Y Y
13 M 26 6 mon Y Y Y Y Y Y Y Y Y
14 M 27 18 mon Y Y Y Y Y Y Y Y Y
15 M 27 10 mon Y Y Y Y Y Y Y Y Y Y
16 M 27 24 mon Y Y Y
17 M 28 10 mon Y Y Y Y Y Y Y Y Y
18 M 28 12 mon Y Y Y Y Y Y Y
19 M 28 14 mon Y Y Y Y Y Y Y Y Y Y
20 M 29 8 mon Y Y Y Y Y Y Y
21 M 29 11 mon Y Y Y Y Y Y Y Y
22 M 29 12 mon Y Y Y Y Y Y Y Y Y Y
23 M 30 12 mon Y Y Y Y Y Y
24 M 30 15 mon Y Y Y Y Y Y Y
25 M 30 18 mon Y Y Y Y Y
26 F 21 6 mon Y Y Y Y Y
27 F 23 6 mon Y Y Y Y Y
28 F 23 10 mon Y Y Y Y Y Y
29 F 24 2 mon Y Y Y Y Y Y
30 F 25 11 mon Y Y Y Y Y
31 F 26 10 mon Y Y Y Y Y Y
32 F 27 24 mon Y Y Y Y Y
33 F 27 18 mon Y Y Y Y Y
34 F 29 6 mon Y Y Y Y Y Y
MiscellaneousDrug induced 
Changes
Bacterial 
Infection
Viral infection 
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Changes
Bacterial 
Infection
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.
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Tinea 
unguium
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35 F 29 10 mon Y Y Y Y Y Y Y
36 M 31 12 mon Y Y Y Y Y Y Y Y Y Y
37 M 31 4 mon Y Y Y Y Y Y
38 M 32 6 mon Y Y Y Y Y
39 M 32 6 mon Y Y Y Y Y
40 M 32 4 mon Y Y Y Y Y Y
41 M 34 8 mon Y Y Y Y Y Y Y Y
42 M 34 12 mon Y Y Y Y Y Y Y Y
43 M 34 8 mon Y Y Y Y Y Y Y Y
44 M 34 12 mon Y Y Y Y Y
45 M 36 15 mon Y Y Y Y Y Y Y Y
46 M 36 18 mon Y Y Y Y Y Y Y Y
47 M 36 12 mon Y Y Y Y Y Y Y
48 M 36 18 mon Y Y Y Y Y Y Y Y Y
49 M 36 16 mon Y Y Y Y Y Y Y Y
50 M 37 16 mon Y Y Y Y Y Y Y Y Y Y Y
51 M 37 14 mon Y Y Y Y Y Y Y
52 M 37 15 mon Y Y Y Y Y
53 M 37 12 mon Y Y Y Y Y
54 M 37 32 mon Y Y Y Y
55 M 37 18 mon Y Y Y Y Y
56 M 37 24 mon Y Y Y
57 M 38 3 mon Y Y Y Y Y Y
58 M 38 6 mon Y Y Y Y Y Y
59 M 38 10 mon Y Y Y Y Y Y
60 M 40 30 mon Y Y Y Y
61 M 40 32 mon Y Y Y Y Y
62 F 32 12 mon Y Y Y Y Y Y Y
63 F 32 10 mon Y Y Y Y Y Y
64 F 34 4 mon Y Y Y Y Y
65 F 34 6 mon Y Y Y Y Y
66 M 41 15 mon Y Y Y Y Y Y Y Y Y Y Y Y
67 M 43 12 mon Y Y Y Y Y Y Y Y Y Y Y
68 M 43 10 mon Y Y Y Y Y Y Y Y
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MiscellaneousDrug induced 
Changes
Bacterial 
Infection
Viral infection 
S
.
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Candi-
diasis
Tinea 
unguium
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69 M 44 6 mon Y Y Y Y Y Y Y
70 M 46 6 mon Y Y Y Y Y Y Y
71 M 46 12 mon Y Y Y Y Y Y Y
72 M 48 12 mon Y Y Y Y
73 M 49 15 mon Y Y Y Y Y
74 M 49 18 mon Y Y Y Y
75 M 50 24 mon Y Y Y
76 F 42 12 mon Y Y Y Y Y
77 M 51 84 mon Y Y Y
78 M 52 48 mon Y Y Y
79 M 52 36 mon Y Y Y
80 M 55 30 mon Y Y Y Y
KEY TO MASTER CHART 
 
C.NO.  - Case Number 
PTI   - Post Transplant Interval 
IMMUNOSUPPRESSIVE DRUGS 
A   - Azathioprine 
P   - Prednisolone 
C   - Cyclosporine 
T   - Tacrolimus 
M   - Mycophenolate mofetil 
 
DERMATOPHYTOSIS 
TC   - Tinea capitis 
TF   - Tinea faciei 
TB   - Tinea barbae 
TC   - Tinea corporis 
TCR   - Tinea cruris 
TG   - Tinea glutealis 
TM   - Tinea manuum 
TP   - Tinea pedis 
TINEA UNGUIUM 
DLSO  - Distal and lateral subungual onychomycosis 
PSWO  - Proximal subungual white onychomycosis 
TDO   - Total dystrophy onychomycosis 
 CANDIDIASIS 
OC   -  Oral Candidiasis  
I   - Intertrigo 
B   - Balanophosthitis 
 
PITYRIASIS VERSICOLOR 
C   - Chromic  
AC   - Achromic 
US   - Usual site 
UUS   - Unusual site 
 
VIRAL INFECTION 
VV   - Verruca vulgaris 
VZ   - Varicella zoster 
HS   - Herpes simplex 
MC   - Molluscum contagiosum 
CP   - Chicken pox 
 
BACTERIAL INFECTION 
I   - Impetigo 
F   - Furuncle 
C   - Cellulitis 
ERS   - Erythrasma 
 DRUG INDUCED CHANGES 
CF   - Cushingoid facies 
AE   - Acneiform eruptions 
ST   - Striae 
HY   - Hypertrichosis 
HI   - Hirsutism 
GH   - Gum hypersplasia 
 
MISCELLANEOUS 
KP   - Keratosis pilaris 
LP   - Lichen planus 
FDE   - Fixed drug eruption 
EI    - Exaggerated insect bite allergy 
SC   - Scabies 
 
 
